Cardiovascular Disease
Maintaining residual kidney function linked to reduced risk of cardiovascular death
Results from a national cohort study of 39,623 patients starting thrice-weekly in-center hemodialysis showed that a lower baseline of urea was consistently associated with greater risk of cardiovascular death.
Top in cardiology: Renal denervation systems get mixed reception from FDA advisors
An FDA advisory panel recently voted that the risks of a radiofrequency renal denervation system outweighed its benefits. The majority was slim, with the panel chair having to step in and break a tie vote.
E-cigarette use rose among ex-smokers with CVD in 2020
E-cigarette use increased overall and in those with a history of CVD who quit cigarette smoking from 2019 to 2020, according to a study published in JAMA Network Open.
Social determinants of health contribute to CVD mortality disparity among Black adults
Social determinants of health significantly contributed to high rates of CVD mortality among Black individuals compared with white individuals, according to researchers.
Sleep apnea hypoxic burden predicts cardiovascular disease, mortality
Obstructive sleep apnea-related increases in hypoxic and ventilatory burdens heightened the risk for cardiovascular disease, according to results published in American Journal of Respiratory and Critical Care Medicine.
‘Lipid paradox’ may obscure cardiovascular risk in patients with inflammatory disease
AUSTIN, Texas — Providers should carefully consider the “lipid paradox” when monitoring cardiovascular risks in patients with rheumatic inflammatory diseases, noted a presenter at the 2023 Rheumatology Nurses Society annual conference.
Black, Hispanic individuals experience poorer outcomes after second cancer diagnosis
An analysis of individuals diagnosed with second primary cancers showed Black individuals exhibited considerably higher risks for cancer-related and cardiovascular-related deaths than white individuals.
Women, underrepresented populations less likely to receive statins
Researchers found a lower prevalence of statin use for primary and secondary atherosclerotic CVD prevention among nonwhite and female patients, which they said may be partially due to factors such as bias and stereotyping.
MACE, malignancy risks similar for upadacitinib, adalimumab in rheumatoid arthritis
Although major adverse cardiac events, malignancy and venous thromboembolism are more frequent in at-risk patients with rheumatoid arthritis, rates are similar between those receiving upadacitinib vs. adalimumab, according to data.
Adults with HIV can lower risk for cardiovascular disease with daily statin, study finds
Adults with HIV can lower their risk for serious cardiovascular events like heart attack or stroke by more than one-third if they take a daily statin, a large phase 3 trial found.